As the U.S. health care system grapples with unrelenting increases in COVID-19 cases during a pandemic that has claimed the lives of more than 400,000 Americans, IDSA and the CDC have extended their partnership to equip frontline health care professionals with the latest information on fighting the disease.
President Biden’s executive orders and national strategy to contain the COVID-19 pandemic, along with renewed participation in the World Health Organization, offer a comprehensive approach with tremendous promise toward ending the nation’s public health crisis.
Antibiotic resistance could be the next epidemic to highlight the impacts of structural racism on health and access to health services, caution the authors of an analysis published in Nature Medicine Monday. The article argues that stronger measures to combat antibiotic resistance should be a key component of broader efforts to promote health equity.
Ten researchers who are exploring the link between an infectious agent and Alzheimer’s disease have each been awarded $100,000 research grants through the IDSA Foundation’s Microbial Pathogenesis in Alzheimer’s Disease Grant program
The Infectious Diseases Society of America and its HIV Medicine Association strongly endorse the executive order signed by President Biden today requiring face masks on federal property and other areas of federal authority for the next 100 days to prevent the spread of COVID-19.
Anthony Fauci, M.D., FIDSA, director of the National Institute of Allergy and Infectious Diseases, kicked off this year’s premier virtual infectious diseases conference with an overview of the public health and scientific challenges of COVID-19 in the United States. Login to this year’s program now.